Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma

British Journal of Dermatology

Volumn 138, Issue 6, 1998, Pages 986-992

  De Fine Olivarius, F ^a   Lock Andersen, J ^a   Gronhoj Larsen F ^a   Wulf, H C ^a   Crosby, J ^b   Norval, M ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UROCANIC ACID;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATHOGENESIS; PRIORITY JOURNAL; SKIN CANCER; SKIN PIGMENTATION; SKINFOLD THICKNESS; ULTRAVIOLET IRRADIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; ISOMERISM; MALE; MELANOMA; MIDDLE AGED; SKIN; SKIN NEOPLASMS; SKIN PIGMENTATION; ULTRAVIOLET RAYS; UROCANIC ACID;

EID: 0031746961     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02264.x     Document Type: Article

References (35)

1. Cooper KD. Cell-mediated immunosuppressive mechanisms induced by UV radiation. Photochem Photobiol 1996; 63: 400-6.
2. Streilein JW, Taylor JR, Vincek V et al. Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. J Invest Dermatol 1994; 103 (Suppl.): S107-11.
3. Baden HP, Pathak MA. The metabolism and function of urocanic acid in skin. J Invest Dermatol 1967; 48: 11-17.
4. Norval M, Simpson TJ, Bardshiri E, Crosby J. Quantification of urocanic acid isomers in human stratum corneum. Photodermatology 1989; 6: 142-5.
5. Kammeyer A, Teunissen MBM, Pavel S et al. Photoisomerisation spectrum of urocanic acid in human skin and in vitro: effects of simulated solar and artificial ultraviolet radiation. Br J Dermatol 1995; 132: 884-91.
6. Norval M, Gibbs NK, Gilmour J. The role of urocanic acid in UV-induced immunosuppression: recent advances (1992-94). Photochem Photobiol 1995; 62: 209-17.
7. Finlay-Jones JJ, Hart PH. Ultraviolet irradiation, systemic immunosuppression and skin cancer: role of urocanic acid. Austral J Dermatol 1997; 38 (Suppl.): S7-12.
8. Kurimoto I, Streilein JW. Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor-alpha. J Invest Dermatol 1992; 99 (Suppl.): S69-70.
9. Lauerma AI, Akihiro A, Maibach HI. Topical cis-urocanic acid suppresses both induction and elicitation of contact hypersensitivity in BALB/C mice. Acta Derm Venereol (Stockh) 1995; 75: 272-5.
10. Gilmour JW, Norval M. The effect of ultraviolet B irradiation, cis-urocanic acid and tumor necrosis factor-alpha on delayed hypersensitivity to herpes simplex virus. Photodermatol Photoimmunol Photomed 1995; 9: 255-61.
11. Garssen J, Norval M, van Loveren H. Role for cis-urocanic acid in UVB induced suppression of resistance to Trichinella spiralis in a rat model. Photochem Photobiol 1996; 63: 99S (Abstr.).
12. Reeve VE, Greenoak GE, Canfield PJ et al. Topical urocanic acid enhances UV-induced tumor yield and malignancy in the hairless mouse. Photochem Photobiol 1989; 49: 459-64.
13. Beissert S, Mohammad T, Torii H et al. Regulation of tumour antigen presentation by urocanic acid. J Immunol 1997; 159: 92-6.
14. Baden HP, Mittler B, Sviokla S, Pathak MA. Urocanic acid in benign and malignant human epidermal tumors. J Natl Cancer Inst 1967; 38: 205-8.
15. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
16. Wulf HC, Lock-Andersen J. The Scandinavian Photodermatology Research Group. Standard erythema dose. Skin Res Technol 1996; 4: 192.
17. Wulf HC. Method and an apparatus for determining an individual's ability to stand exposure to ultraviolet irradiation. United States Patent no. 4.882.598. 1989; 1-32.
18. Bech-Thomsen N, Ravnborg L, Wulf HC. A quantitative study of the melanogenic effect of multiple suberythemal doses of different ultraviolet radiation sources. Photodermatol Photoimmunol Photomed 1994; 10: 53-6.
19. Jansén CT, Lammintausta K, Pasanen P et al. A non-invasive chamber sampling technique for HPLC analysis of human epidermal urocanic acid isomers. Acta Derm Venereol (Stockh) 1991; 71: 143-5.
20. Gibbs NK, Norval M, Traynor NJ et al. Action spectra for the trans to cis photoisomerisation of urocanic acid in vitro and in mouse skin. Photochem Photobiol 1993; 57: 584-90. (Correction: Photochem Photobiol 1993; 58: 769).
21. McKinlay AF, Diffey BL. A reference spectrum for ultraviolet induced erythema in human skin. Commission Inte de l'Eclairage (CIE) 1987; J.6: 17-22.
22. Pathak MA, Fitzpatrick TB. The role of natural photoprotective agents in human skin. In: Sunlight and Man (Fitzpatrick TB, ed.). Tokyo: University of Tokyo Press, 1974.
23. Lock-Andersen J, Therkildsen P, de Fine Olivarius F et al. Epidermal thickness, skin pigmentation and constitutive photosensitivity. Photodermatol Photoimmunol Photomed (in press).
24. Kavanagh G, Crosby J, Norval M. Urocanic acid isomers in human skin: analysis of site variance. Br J Dermatol 1995; 133: 728-31.
25. de Fine Olivarius F, Wulf HC, Therkildsen P et al. Urocanic acid isomers: relation to body site, pigmentation, stratum corneum thickness and photosensitivity. Arch Dermatol Res 1997; 289: 501-5.
26. de Fine Olivarius F, Wulf HC, Crosby J, Norval M. The sunscreening effect of urocanic acid. Photodermatol Photoimmunol Photomed 1996; 12: 95-9.
27. Reilly SK, De Fabo EC. Dietary histidine increases mouse skin urocanic acid levels and enhances UVB-induced immune suppression of contact hypersensitivity. Photochem Photobiol 1991; 53: 431-8.
28. Reeve VE, Mitchell LE. Hazards of urocanic acid as a cosmetic ingredient. Photodermatol Photoimmunol Photomed 1991; 8: 176-80.
29. Yoshikawa T, Rae V, Bruins-Slot W et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990; 95: 530-6.
30. Noonan FP, De Fabo EC, Morrison H. Cis-urocanic acid, a product formed by ultraviolet B irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo. J Invest Dermatol 1988; 90: 92-9.
31. El-Ghorr AA, Norval M. A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J Invest Dermatol 1995; 105: 264-8.
32. Kammeyer A, Pavel S, Asghar SS et al. Prolonged increase of cis-urocanic acid levels in human skin and urine after single total-body ultraviolet exposures. Photochem Photobiol 1997; 65: 593-8.
33. Lock-Andersen J, Gniadecka M, de Fine Olivarius F et al. UV induced erythema evaluated 24 hours post-exposure by skin reflectance and laser Doppler flowmetry is identical in healthy persons and patients with cutaneous malignant melanoma and basal cell cancer. J Photochem Photobiol B Bioll 1997; 41: 30-5.
34. Ross JA, Howie SEM, Norval M et al. Ultraviolet-irradiated urocanic acid suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J Invest Dermatol 1986; 87: 630-3.
35. Norval M, Simpson TJ, Bardshiri E, Howie SEM. Urocanic acid analogues and the suppression of the delayed type hypersensitivity responses to herpes simplex virus. Photochem Photobiol 1989; 49: 633-69.